Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMARTCIT – A novel citrate-based anticoagulation for CRRT
2010-018553-35Phase 2Completed
- Sponsor
- Baxter International Inc.
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of trisodium citrate in acute kidney failure (AKF), sponsored by Baxter International Inc. Primary endpoint: Extracorporeal ionized calcium concentration. Started Mar 2010; status: completed.
02
Drugs
trisodium citrate
03
Conditions
acute kidney failure (AKF)
Beyond the preview
Go deeper on 2010-018553-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-018553-35.